Search
Anavex Life Sciences Corp
AVXLAdd to Watchlist
3.240USD
+0.110+3.51%
Close 08-21 16:00（ET）
299.79MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-21The current earnings forecast score of Anavex Life Sciences Corp is 8.00, ranking 168 out of 377 in the Biotechnology & Medical Research industry. The average price target is 22.00, with a high of 24.00 and a low of 20.00.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
20.000
Target Price
+525.00%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Anavex Life Sciences Corp
AVXL
1
Beigene Ltd
ONC
28
argenx SE
ARGX
28
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Anavex Life Sciences Corp's price target?
Analysts forecast that Anavex Life Sciences Corp's price target is USD 22.00, with the highest forecast at USD 24.00 and the lowest forecast at USD 20.00.
How have Anavex Life Sciences CorpAVXL's recent earnings per share performed?
The market expectation was USD -0.06, while Anavex Life Sciences CorpAVXL's earnings per share (EPS) for the previous quarter was USD -0.11. EPS for the next quarter is expected at USD -0.07.
What is the analyst rating for Anavex Life Sciences Corp?
Based on the ratings of Anavex Life Sciences Corp's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.